Tr1x, Inc.
Clinical trials sponsored by Tr1x, Inc., explained in plain language.
-
Experimental cell treatment offers hope for Crohn's patients Who've tried everything else
Disease control Recruiting nowThis early-stage study is testing a new cell therapy called TRX103 for people with moderate-to-severe Crohn's disease that hasn't responded to at least two standard treatments. Researchers will give different doses to 39 participants to check safety and see if it reduces gut infl…
Phase: PHASE1, PHASE2 • Sponsor: Tr1X, Inc. • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC
-
New MS therapy enters human testing
Disease control Recruiting nowThis early-stage study is testing a new therapy called TRX319 in adults with progressive forms of multiple sclerosis (MS). The main goals are to check if the treatment is safe, find the best dose, and see if a pre-treatment step is helpful. About 39 participants will be monitored…
Phase: PHASE1, PHASE2 • Sponsor: Tr1X, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC